longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Sanofi

SNY

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Sanofi(SNY) the Revenue is 13.25 B (+13.27%), Beat estimate;the EBIT is 3.76 B (+30.53%), Beat estimate;the EPS is 0.167 (-90.99%), Miss estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
13.25B13.27%
12.44B6.37%
+0.81B6.90%
EBITExceed expectations
3.76B30.53%
3.39B17.83%
+0.37B12.70%
EPSMiss expectations
0.166990.99%
0.57768.86%
-0.410122.13%

Upcoming earnings report - Q3 FY2026

Available dateOct 30, 2026
Estimate Revenue$15.22 B
Estimate EBIT--
Estimate EPS$0.9654

Revenue

ActualEstimateUnit: USD
qf

EBIT

ActualEstimateUnit: USD
qf

Net income

ActualEstimateUnit: USD
qf

EPS

ActualEstimateUnit: USD
qf